What Can We Expect for the Autoimmune Treatment Market in the Future?
The autoimmune treatment market size has grown rapidly in recent years. It is forecasted to grow from $7.72 billion in 2024 to $8.66 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing prevalence, advancements in immunology, genetic research insights, patient awareness, advocacy, and regulatory support.
Looking forward, the autoimmune treatment market size is expected to see rapid growth. It will reach $14.66 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. This promising growth in the forecast period can be attributed to precision medicine approaches, emergence of small molecule therapies, targeting novel pathways, gene therapy innovations, increasing biopharmaceutical investments, biosimilar market growth. Major trends in the forecast period include advancements in biologics and targeted therapies, immunomodulatory therapies, focus on rare autoimmune diseases, telemedicine and remote monitoring, regulatory initiatives and drug approvals, and integration of digital health tools.
Get Your Free Sample of The Global Autoimmune Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp
What is Behind the Rapid Growth of the Autoimmune Treatment Market?
The increase in investments in research and development of drugs for autoimmune diseases are expected to propel the growth of the autoimmune treatment market going forward. Research and development are key for businesses to innovate and launch new goods and services, especially in the treatment of autoimmune diseases.
What are the Key Segments within the Global Autoimmune Treatment Market?
The autoimmune treatment market covered in this report is segmented as follows:
1) By Product: Consumables And Assay Kits, Instruments, Services
2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development
3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Who are the Major Players in the Autoimmune Treatment Market?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.
What are the Emerging Trends in the Autoimmune Treatment Market?
Technological advancements are a key trend gaining popularity in the autoimmune treatment market. For instance, in June 2023, UCB, a Belgium-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO in the treatment of generalized myasthenia gravis (gMG) in adults.
Which Region Dominates the Autoimmune Treatment Market?
North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Autoimmune Treatment Market Report 2025 Offer?
Autoimmune treatment refers to the management and care of a patient for the purpose of combating an autoimmune disease or disorder. This is a condition in which one’s immune system starts attacking its own body cells. The autoimmune treatment is used to treat these diseases. The Autoimmune Treatment Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7863
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
